Please assess the completion status of the following clinical trial:

Trial Title: Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* The patients who experienced fewer than three SBMs per week for more than 6 months prior to the enrollment.~* The patients who experienced one or more of the following signs or symptoms during more than 25% of bowel movements for more than 6 months: straining, lumpy or hard stools, and a sensation of incomplete evacuation.~Exclusion Criteria:~* Patients who have secondary constipation caused by systemic disorder.~* Patients who have organic constipation.~* Patients who received intestinal resection.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- KWA-0711 High dose (Type: EXPERIMENTAL): None
- KWA-0711 Low dose (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).